Neonatal hepatitis: Difference between revisions
Ostermayer (talk | contribs) (Created page with "Neonatal hepatitis is a clinical syndrome of hepatic inflammation and '''conjugated (direct) hyperbilirubinemia''' in the newborn, representing over 100 possible underlying etiologies ranging from benign self-limited conditions to life-threatening emergencies.<ref name="NeoChol">Neonatal Cholestasis. ''Pediatr Rev''. 2014;35(10):436-443. doi:10.1542/pir.35-10-436</ref> The critical task for the emergency physician is to '''recognize conjugated hyperbilirubinemia as alway...") |
(Strip excess bold) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Neonatal cholestasis occurs in approximately | *Neonatal hepatitis is a clinical syndrome of hepatic inflammation and conjugated (direct) hyperbilirubinemia in the newborn, representing over 100 possible underlying etiologies ranging from benign self-limited conditions to life-threatening emergencies.<ref name="NeoChol">Neonatal Cholestasis. ''Pediatr Rev''. 2014;35(10):436-443. doi:10.1542/pir.35-10-436</ref> The critical task for the emergency physician is to recognize conjugated hyperbilirubinemia as always pathologic, distinguish it from benign physiologic jaundice, initiate a systematic workup, and urgently identify time-sensitive diagnoses — especially [[Biliary atresia|biliary atresia]] (which requires surgery before 60 days of life) and fulminant causes (sepsis, HSV, galactosemia, [[Tyrosinemia|tyrosinemia]]).<ref name="NASPGHAN">Guideline for the Evaluation of Cholestatic Jaundice in Infants. Joint NASPGHAN/ESPGHAN. ''J Pediatr Gastroenterol Nutr''. 2017;64(1):154-168.</ref> | ||
*Neonatal cholestasis occurs in approximately 1 in 2,500 live births<ref name="Frontiers">Götze T, et al. Neonatal Cholestasis – Differential Diagnoses, Current Diagnostic Procedures, and Treatment. ''Front Pediatr''. 2015;3:43. doi:10.3389/fped.2015.00043</ref> | |||
*'''Conjugated (direct) hyperbilirubinemia is NEVER physiologic and NEVER normal''' — it always requires evaluation<ref name="NeoChol"/> | *'''Conjugated (direct) hyperbilirubinemia is NEVER physiologic and NEVER normal''' — it always requires evaluation<ref name="NeoChol"/> | ||
*Definition of conjugated hyperbilirubinemia: | *Definition of conjugated hyperbilirubinemia: | ||
**Direct bilirubin | **Direct bilirubin > 1 mg/dL (regardless of total bilirubin), OR | ||
**Direct bilirubin | **Direct bilirubin > 20% of total bilirubin (if total > 5 mg/dL)<ref name="NASPGHAN"/> | ||
*The term "neonatal hepatitis" historically referred to | *The term "neonatal hepatitis" historically referred to "idiopathic neonatal hepatitis" (a diagnosis of exclusion after all identifiable causes are ruled out) — this accounts for ~26% of cases<ref name="Gottesman">Gottesman LE, et al. Etiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjects. ''BMC Pediatr''. 2015;15:192. doi:10.1186/s12887-015-0506-5</ref> | ||
*Most common identifiable causes:<ref name="Gottesman"/> | *Most common identifiable causes:<ref name="Gottesman"/> | ||
** | ** [[Biliary atresia]] (~26%) — the most time-sensitive surgical diagnosis | ||
** | ** Infections (~11%) — CMV is the most common infectious cause | ||
** | ** TPN-associated cholestasis (~6%) | ||
** | ** Alpha-1 antitrypsin deficiency (~4%) | ||
** | ** Metabolic diseases (~4%) — [[Galactosemia|galactosemia]], [[Tyrosinemia|tyrosinemia type 1]], [[Cystinosis|cystinosis]] | ||
** | ** Perinatal hypoxia/ischemia (~4%) | ||
===EM critical rule=== | ===EM critical rule=== | ||
* | * Any infant jaundiced beyond 2 weeks of age (3 weeks if breastfed and otherwise well) must have a fractionated bilirubin — this single step prevents the most consequential missed diagnosis<ref name="NASPGHAN"/> | ||
==Clinical features== | ==Clinical features== | ||
===Cardinal triad of neonatal cholestasis=== | ===Cardinal triad of neonatal cholestasis=== | ||
* | * Jaundice (persisting beyond 2 weeks) | ||
* | * Acholic (pale/clay-colored) stools — absent bile pigment indicates biliary obstruction | ||
* | * Dark urine (conjugated bilirubin excreted renally) | ||
===Features suggesting specific etiologies=== | ===Features suggesting specific etiologies=== | ||
| Line 29: | Line 28: | ||
====Biliary atresia (most time-sensitive)==== | ====Biliary atresia (most time-sensitive)==== | ||
*Term infant, often appears well initially | *Term infant, often appears well initially | ||
*Progressive jaundice with | *Progressive jaundice with acholic stools (single most important clue) | ||
*Hepatomegaly (firm liver) | *Hepatomegaly (firm liver) | ||
*May have associated | *May have associated situs inversus or polysplenia (biliary atresia splenic malformation syndrome) | ||
* | * No hepatic synthetic failure early (unlike metabolic/infectious causes) | ||
*'''Kasai hepatoportoenterostomy must be performed before 60 days of age''' for best outcomes; delays worsen prognosis dramatically<ref name="NASPGHAN"/> | *'''Kasai hepatoportoenterostomy must be performed before 60 days of age''' for best outcomes; delays worsen prognosis dramatically<ref name="NASPGHAN"/> | ||
====Infectious causes (may present as sepsis)==== | ====Infectious causes (may present as sepsis)==== | ||
* | * [[Neonatal HSV|Neonatal herpes simplex (HSV)]] — fulminant liver failure, DIC, vesicular rash (may be absent), seizures; '''acyclovir must be started empirically if suspected''' | ||
* | * [[TORCH infections|TORCH]] — toxoplasmosis, rubella, CMV, HSV, syphilis; may present with hepatosplenomegaly, petechiae, microcephaly, chorioretinitis, intracranial calcifications | ||
* | * Bacterial [[Sepsis|sepsis]] — UTI (especially ''E. coli'') is a common cause of cholestasis in young infants; gram-negative sepsis | ||
* | * Enterovirus, adenovirus, parvovirus B19 | ||
====Metabolic emergencies==== | ====Metabolic emergencies==== | ||
* | * [[Galactosemia]] — vomiting, poor feeding, hepatomegaly after introduction of lactose-containing formula/breast milk; '''E. coli sepsis''' association; cataracts; reducing substances in urine; '''STOP galactose-containing feeds immediately''' | ||
* | * [[Tyrosinemia|Tyrosinemia type 1]] — liver failure with coagulopathy out of proportion to transaminases; very high AFP; "boiled cabbage" odor; [[Fanconi syndrome]] | ||
* | * Hereditary fructose intolerance — hepatic failure after introduction of fructose/sucrose to diet | ||
* | * [[Neonatal hemochromatosis]] (gestational alloimmune liver disease; GALD) — severe liver failure present at birth or within hours; high ferritin; requires exchange transfusion/IVIG | ||
* | * Hypothyroidism — may present with prolonged jaundice; check TSH | ||
* | * Cystic fibrosis — meconium ileus history; may present with cholestasis | ||
====Other causes==== | ====Other causes==== | ||
* | * Alpha-1 antitrypsin deficiency — most common genetic cause of liver disease in children; may present as neonatal cholestasis or later as cirrhosis | ||
* | * Alagille syndrome — characteristic facies (broad forehead, pointed chin, deep-set eyes), butterfly vertebrae, cardiac murmur (peripheral pulmonic stenosis), posterior embryotoxon on eye exam | ||
* | * Progressive familial intrahepatic cholestasis (PFIC) — various subtypes; severe pruritus (may not be apparent in neonates) | ||
* | * TPN-associated cholestasis — in premature infants receiving prolonged parenteral nutrition | ||
* | * Choledochal cyst — may present as a palpable RUQ mass with jaundice | ||
===General examination findings=== | ===General examination findings=== | ||
| Line 61: | Line 60: | ||
*Growth failure, poor feeding | *Growth failure, poor feeding | ||
*Coagulopathy/bleeding (vitamin K deficiency from fat malabsorption, or hepatic synthetic failure) | *Coagulopathy/bleeding (vitamin K deficiency from fat malabsorption, or hepatic synthetic failure) | ||
* | * Stool color is critically important — ask caregivers and inspect stools directly | ||
==Differential diagnosis== | ==Differential diagnosis== | ||
===Must-not-miss (time-sensitive or life-threatening)=== | ===Must-not-miss (time-sensitive or life-threatening)=== | ||
* | * [[Biliary atresia]] — surgery before 60 days | ||
* | * [[Neonatal HSV]] — acyclovir immediately | ||
* | * Bacterial [[Sepsis|sepsis]]/UTI — antibiotics immediately | ||
* | * [[Galactosemia]] — stop lactose immediately | ||
* | * [[Tyrosinemia|Tyrosinemia type 1]] — start nitisinone | ||
* | * [[Neonatal hemochromatosis]] (GALD) — exchange transfusion/IVIG | ||
===Common causes=== | ===Common causes=== | ||
| Line 84: | Line 83: | ||
*Hemolytic disease (ABO/Rh incompatibility) | *Hemolytic disease (ABO/Rh incompatibility) | ||
*[[Gilbert syndrome]], [[Crigler-Najjar syndrome]] | *[[Gilbert syndrome]], [[Crigler-Najjar syndrome]] | ||
* | * These are distinguished by fractionated bilirubin — the direct fraction will be normal | ||
==Evaluation== | ==Evaluation== | ||
===ED workup=== | ===ED workup=== | ||
* | * Fractionated (total and direct) bilirubin — the single most important initial test; identifies conjugated hyperbilirubinemia<ref name="NASPGHAN"/> | ||
* | * Hepatic function panel: AST, ALT, GGT, alkaline phosphatase, albumin | ||
**GGT is particularly useful: markedly elevated in biliary atresia and bile duct disorders; normal/low in PFIC | **GGT is particularly useful: markedly elevated in biliary atresia and bile duct disorders; normal/low in PFIC | ||
* | * Coagulation studies (PT/INR): hepatic synthetic function; also assesses vitamin K deficiency | ||
* | * CBC with differential: infection, anemia, thrombocytopenia | ||
* | * Blood glucose: hypoglycemia (metabolic diseases, liver failure) | ||
* | * BMP: electrolytes, renal function | ||
* | * Blood cultures, urinalysis, urine culture — sepsis/UTI workup in any ill-appearing infant | ||
* | * Newborn screening results — review if available; many metabolic causes are screened | ||
===Directed second-tier testing (initiate from ED or arrange urgently)=== | ===Directed second-tier testing (initiate from ED or arrange urgently)=== | ||
* | * Abdominal ultrasound: evaluate for biliary atresia (absent/atretic gallbladder, triangular cord sign), choledochal cyst, gallstones; does not reliably exclude biliary atresia | ||
* | * TORCH titers/PCR: CMV urine PCR, HSV PCR, rubella, toxoplasmosis, syphilis (RPR/VDRL) | ||
* | * Urine reducing substances: positive in galactosemia (but not specific; false negatives occur) | ||
* | * TSH, free T4: hypothyroidism | ||
* | * Alpha-1 antitrypsin level and phenotype | ||
* | * Urine succinylacetone: pathognomonic for [[Tyrosinemia|tyrosinemia type 1]] | ||
* | * Serum ferritin, transferrin saturation: neonatal hemochromatosis (ferritin often massively elevated) | ||
* | * AFP (alpha-fetoprotein): markedly elevated in tyrosinemia; elevated in normal neonates but should be declining | ||
* | * Sweat chloride or immunoreactive trypsinogen: if cystic fibrosis suspected | ||
* | * Galactose-1-phosphate uridylyltransferase (GALT) activity: confirms galactosemia | ||
===When to suspect biliary atresia=== | ===When to suspect biliary atresia=== | ||
*Full-term infant with | *Full-term infant with persistent acholic stools + conjugated hyperbilirubinemia + hepatomegaly | ||
*GGT markedly elevated | *GGT markedly elevated | ||
*Absent or atretic gallbladder on ultrasound (though ultrasound sensitivity is imperfect) | *Absent or atretic gallbladder on ultrasound (though ultrasound sensitivity is imperfect) | ||
* | * Refer urgently to pediatric surgery/hepatology — do not wait for complete workup if clinical suspicion is high; intraoperative cholangiogram is the gold standard | ||
==Management== | ==Management== | ||
===Immediate ED management=== | ===Immediate ED management=== | ||
* | * Vitamin K: administer 1 mg IM (neonatal dose) to any infant with cholestasis and coagulopathy — fat-soluble vitamin malabsorption causes vitamin K deficiency and bleeding risk; this can be life-saving<ref name="Merck">Neonatal Cholestasis. ''Merck Manual Professional Edition''. 2025.</ref> | ||
* | * NPO if acutely ill until stabilized; IV dextrose-containing fluids to prevent hypoglycemia | ||
* | * Empiric antibiotics if sepsis suspected (ampicillin + gentamicin or cefotaxime per neonatal protocol) | ||
* | * Empiric acyclovir if '''any''' suspicion for neonatal HSV (do not wait for HSV PCR results; disseminated HSV with hepatitis carries >80% mortality without treatment)<ref name="NASPGHAN"/> | ||
* | * Stop galactose-containing feeds (breast milk and standard lactose-based formula) if galactosemia suspected — switch to soy-based formula | ||
* | * Stop fructose/sucrose if hereditary fructose intolerance suspected | ||
* | * Correct coagulopathy with vitamin K; FFP if active bleeding | ||
* | * Correct hypoglycemia with IV dextrose | ||
===Supportive care=== | ===Supportive care=== | ||
| Line 133: | Line 132: | ||
===Disease-specific management (arrange via specialist)=== | ===Disease-specific management (arrange via specialist)=== | ||
* | * Biliary atresia: Kasai hepatoportoenterostomy (ideally before day 45-60 of life) | ||
* | * Tyrosinemia type 1: nitisinone + low-tyrosine diet (see [[Tyrosinemia]]) | ||
* | * Galactosemia: strict galactose-free diet | ||
* | * Neonatal hemochromatosis (GALD): exchange transfusion + IVIG (consult neonatology/hepatology emergently) | ||
* | * Alpha-1 antitrypsin deficiency: supportive; liver transplant if progressive | ||
* | * Hypothyroidism: levothyroxine | ||
==Disposition== | ==Disposition== | ||
* | * All infants with confirmed conjugated hyperbilirubinemia should be admitted or have same-day/next-day urgent pediatric GI/hepatology follow-up arranged from the ED<ref name="NASPGHAN"/> | ||
* | * Admit to hospital (often NICU/PICU): | ||
**Any ill-appearing infant | **Any ill-appearing infant | ||
**Suspected sepsis, HSV, or metabolic emergency | **Suspected sepsis, HSV, or metabolic emergency | ||
| Line 148: | Line 147: | ||
**Hepatic failure (elevated INR, hypoglycemia, encephalopathy) | **Hepatic failure (elevated INR, hypoglycemia, encephalopathy) | ||
**Suspected biliary atresia — urgent surgical consultation | **Suspected biliary atresia — urgent surgical consultation | ||
* | * Urgent outpatient referral (if well-appearing, stable, feeding well): | ||
**Conjugated hyperbilirubinemia confirmed but infant is clinically well | **Conjugated hyperbilirubinemia confirmed but infant is clinically well | ||
**Pediatric GI/hepatology appointment within | **Pediatric GI/hepatology appointment within 24-48 hours | ||
**Ensure caregivers understand return precautions: fever, pale stools, increasing jaundice, bleeding, poor feeding, lethargy | **Ensure caregivers understand return precautions: fever, pale stools, increasing jaundice, bleeding, poor feeding, lethargy | ||
* | * Communicate stool color education: provide caregivers with a '''stool color card''' if available (used in some countries for biliary atresia screening); instruct them to report acholic/pale stools immediately | ||
*'''Do not attribute persistent jaundice beyond 2 weeks to "breast milk jaundice" without fractionating bilirubin''' — this is the most common cause of delayed diagnosis of biliary atresia and other serious conditions | *'''Do not attribute persistent jaundice beyond 2 weeks to "breast milk jaundice" without fractionating bilirubin''' — this is the most common cause of delayed diagnosis of biliary atresia and other serious conditions | ||
Latest revision as of 09:30, 22 March 2026
Background
- Neonatal hepatitis is a clinical syndrome of hepatic inflammation and conjugated (direct) hyperbilirubinemia in the newborn, representing over 100 possible underlying etiologies ranging from benign self-limited conditions to life-threatening emergencies.[1] The critical task for the emergency physician is to recognize conjugated hyperbilirubinemia as always pathologic, distinguish it from benign physiologic jaundice, initiate a systematic workup, and urgently identify time-sensitive diagnoses — especially biliary atresia (which requires surgery before 60 days of life) and fulminant causes (sepsis, HSV, galactosemia, tyrosinemia).[2]
- Neonatal cholestasis occurs in approximately 1 in 2,500 live births[3]
- Conjugated (direct) hyperbilirubinemia is NEVER physiologic and NEVER normal — it always requires evaluation[1]
- Definition of conjugated hyperbilirubinemia:
- Direct bilirubin > 1 mg/dL (regardless of total bilirubin), OR
- Direct bilirubin > 20% of total bilirubin (if total > 5 mg/dL)[2]
- The term "neonatal hepatitis" historically referred to "idiopathic neonatal hepatitis" (a diagnosis of exclusion after all identifiable causes are ruled out) — this accounts for ~26% of cases[4]
- Most common identifiable causes:[4]
- Biliary atresia (~26%) — the most time-sensitive surgical diagnosis
- Infections (~11%) — CMV is the most common infectious cause
- TPN-associated cholestasis (~6%)
- Alpha-1 antitrypsin deficiency (~4%)
- Metabolic diseases (~4%) — galactosemia, tyrosinemia type 1, cystinosis
- Perinatal hypoxia/ischemia (~4%)
EM critical rule
- Any infant jaundiced beyond 2 weeks of age (3 weeks if breastfed and otherwise well) must have a fractionated bilirubin — this single step prevents the most consequential missed diagnosis[2]
Clinical features
Cardinal triad of neonatal cholestasis
- Jaundice (persisting beyond 2 weeks)
- Acholic (pale/clay-colored) stools — absent bile pigment indicates biliary obstruction
- Dark urine (conjugated bilirubin excreted renally)
Features suggesting specific etiologies
Biliary atresia (most time-sensitive)
- Term infant, often appears well initially
- Progressive jaundice with acholic stools (single most important clue)
- Hepatomegaly (firm liver)
- May have associated situs inversus or polysplenia (biliary atresia splenic malformation syndrome)
- No hepatic synthetic failure early (unlike metabolic/infectious causes)
- Kasai hepatoportoenterostomy must be performed before 60 days of age for best outcomes; delays worsen prognosis dramatically[2]
Infectious causes (may present as sepsis)
- Neonatal herpes simplex (HSV) — fulminant liver failure, DIC, vesicular rash (may be absent), seizures; acyclovir must be started empirically if suspected
- TORCH — toxoplasmosis, rubella, CMV, HSV, syphilis; may present with hepatosplenomegaly, petechiae, microcephaly, chorioretinitis, intracranial calcifications
- Bacterial sepsis — UTI (especially E. coli) is a common cause of cholestasis in young infants; gram-negative sepsis
- Enterovirus, adenovirus, parvovirus B19
Metabolic emergencies
- Galactosemia — vomiting, poor feeding, hepatomegaly after introduction of lactose-containing formula/breast milk; E. coli sepsis association; cataracts; reducing substances in urine; STOP galactose-containing feeds immediately
- Tyrosinemia type 1 — liver failure with coagulopathy out of proportion to transaminases; very high AFP; "boiled cabbage" odor; Fanconi syndrome
- Hereditary fructose intolerance — hepatic failure after introduction of fructose/sucrose to diet
- Neonatal hemochromatosis (gestational alloimmune liver disease; GALD) — severe liver failure present at birth or within hours; high ferritin; requires exchange transfusion/IVIG
- Hypothyroidism — may present with prolonged jaundice; check TSH
- Cystic fibrosis — meconium ileus history; may present with cholestasis
Other causes
- Alpha-1 antitrypsin deficiency — most common genetic cause of liver disease in children; may present as neonatal cholestasis or later as cirrhosis
- Alagille syndrome — characteristic facies (broad forehead, pointed chin, deep-set eyes), butterfly vertebrae, cardiac murmur (peripheral pulmonic stenosis), posterior embryotoxon on eye exam
- Progressive familial intrahepatic cholestasis (PFIC) — various subtypes; severe pruritus (may not be apparent in neonates)
- TPN-associated cholestasis — in premature infants receiving prolonged parenteral nutrition
- Choledochal cyst — may present as a palpable RUQ mass with jaundice
General examination findings
- Hepatomegaly (nearly universal in cholestasis)
- Splenomegaly (suggests portal hypertension, storage disease, or infection)
- Growth failure, poor feeding
- Coagulopathy/bleeding (vitamin K deficiency from fat malabsorption, or hepatic synthetic failure)
- Stool color is critically important — ask caregivers and inspect stools directly
Differential diagnosis
Must-not-miss (time-sensitive or life-threatening)
- Biliary atresia — surgery before 60 days
- Neonatal HSV — acyclovir immediately
- Bacterial sepsis/UTI — antibiotics immediately
- Galactosemia — stop lactose immediately
- Tyrosinemia type 1 — start nitisinone
- Neonatal hemochromatosis (GALD) — exchange transfusion/IVIG
Common causes
- Idiopathic neonatal hepatitis (diagnosis of exclusion)
- TORCH infections (especially CMV)
- TPN-associated cholestasis (premature infants)
- Alpha-1 antitrypsin deficiency
- Alagille syndrome
Conditions that mimic cholestasis (unconjugated)
- Physiologic jaundice (unconjugated; resolves by 2 weeks)
- Breast milk jaundice (unconjugated; benign; may persist 3+ weeks)
- Hemolytic disease (ABO/Rh incompatibility)
- Gilbert syndrome, Crigler-Najjar syndrome
- These are distinguished by fractionated bilirubin — the direct fraction will be normal
Evaluation
ED workup
- Fractionated (total and direct) bilirubin — the single most important initial test; identifies conjugated hyperbilirubinemia[2]
- Hepatic function panel: AST, ALT, GGT, alkaline phosphatase, albumin
- GGT is particularly useful: markedly elevated in biliary atresia and bile duct disorders; normal/low in PFIC
- Coagulation studies (PT/INR): hepatic synthetic function; also assesses vitamin K deficiency
- CBC with differential: infection, anemia, thrombocytopenia
- Blood glucose: hypoglycemia (metabolic diseases, liver failure)
- BMP: electrolytes, renal function
- Blood cultures, urinalysis, urine culture — sepsis/UTI workup in any ill-appearing infant
- Newborn screening results — review if available; many metabolic causes are screened
Directed second-tier testing (initiate from ED or arrange urgently)
- Abdominal ultrasound: evaluate for biliary atresia (absent/atretic gallbladder, triangular cord sign), choledochal cyst, gallstones; does not reliably exclude biliary atresia
- TORCH titers/PCR: CMV urine PCR, HSV PCR, rubella, toxoplasmosis, syphilis (RPR/VDRL)
- Urine reducing substances: positive in galactosemia (but not specific; false negatives occur)
- TSH, free T4: hypothyroidism
- Alpha-1 antitrypsin level and phenotype
- Urine succinylacetone: pathognomonic for tyrosinemia type 1
- Serum ferritin, transferrin saturation: neonatal hemochromatosis (ferritin often massively elevated)
- AFP (alpha-fetoprotein): markedly elevated in tyrosinemia; elevated in normal neonates but should be declining
- Sweat chloride or immunoreactive trypsinogen: if cystic fibrosis suspected
- Galactose-1-phosphate uridylyltransferase (GALT) activity: confirms galactosemia
When to suspect biliary atresia
- Full-term infant with persistent acholic stools + conjugated hyperbilirubinemia + hepatomegaly
- GGT markedly elevated
- Absent or atretic gallbladder on ultrasound (though ultrasound sensitivity is imperfect)
- Refer urgently to pediatric surgery/hepatology — do not wait for complete workup if clinical suspicion is high; intraoperative cholangiogram is the gold standard
Management
Immediate ED management
- Vitamin K: administer 1 mg IM (neonatal dose) to any infant with cholestasis and coagulopathy — fat-soluble vitamin malabsorption causes vitamin K deficiency and bleeding risk; this can be life-saving[5]
- NPO if acutely ill until stabilized; IV dextrose-containing fluids to prevent hypoglycemia
- Empiric antibiotics if sepsis suspected (ampicillin + gentamicin or cefotaxime per neonatal protocol)
- Empiric acyclovir if any suspicion for neonatal HSV (do not wait for HSV PCR results; disseminated HSV with hepatitis carries >80% mortality without treatment)[2]
- Stop galactose-containing feeds (breast milk and standard lactose-based formula) if galactosemia suspected — switch to soy-based formula
- Stop fructose/sucrose if hereditary fructose intolerance suspected
- Correct coagulopathy with vitamin K; FFP if active bleeding
- Correct hypoglycemia with IV dextrose
Supportive care
- Fat-soluble vitamin supplementation (A, D, E, K) — arrange through pediatric GI
- For formula-fed infants: MCT-enriched formula (medium-chain triglycerides are absorbed without bile salts)
- Ursodeoxycholic acid (UDCA) — choleretic agent; may be started by GI/hepatology for some causes of intrahepatic cholestasis
Disease-specific management (arrange via specialist)
- Biliary atresia: Kasai hepatoportoenterostomy (ideally before day 45-60 of life)
- Tyrosinemia type 1: nitisinone + low-tyrosine diet (see Tyrosinemia)
- Galactosemia: strict galactose-free diet
- Neonatal hemochromatosis (GALD): exchange transfusion + IVIG (consult neonatology/hepatology emergently)
- Alpha-1 antitrypsin deficiency: supportive; liver transplant if progressive
- Hypothyroidism: levothyroxine
Disposition
- All infants with confirmed conjugated hyperbilirubinemia should be admitted or have same-day/next-day urgent pediatric GI/hepatology follow-up arranged from the ED[2]
- Admit to hospital (often NICU/PICU):
- Any ill-appearing infant
- Suspected sepsis, HSV, or metabolic emergency
- Coagulopathy or active bleeding
- Hepatic failure (elevated INR, hypoglycemia, encephalopathy)
- Suspected biliary atresia — urgent surgical consultation
- Urgent outpatient referral (if well-appearing, stable, feeding well):
- Conjugated hyperbilirubinemia confirmed but infant is clinically well
- Pediatric GI/hepatology appointment within 24-48 hours
- Ensure caregivers understand return precautions: fever, pale stools, increasing jaundice, bleeding, poor feeding, lethargy
- Communicate stool color education: provide caregivers with a stool color card if available (used in some countries for biliary atresia screening); instruct them to report acholic/pale stools immediately
- Do not attribute persistent jaundice beyond 2 weeks to "breast milk jaundice" without fractionating bilirubin — this is the most common cause of delayed diagnosis of biliary atresia and other serious conditions
See Also
- Neonatal jaundice
- Biliary atresia
- Neonatal HSV
- Galactosemia
- Tyrosinemia
- Fanconi syndrome
- Cystinosis
- Sepsis
- TORCH infections
- Neonatal hemochromatosis
External Links
- NASPGHAN/ESPGHAN — Guideline for the Evaluation of Cholestatic Jaundice in Infants (2017)
- Pediatr Rev — Neonatal Cholestasis (2014)
- BMC Pediatr — Etiologies of conjugated hyperbilirubinemia in infancy (2015)
- Front Pediatr — Neonatal Cholestasis: Differential Diagnoses, Current Diagnostic Procedures, and Treatment (2015)
- Merck Manual — Neonatal Cholestasis
References
- ↑ 1.0 1.1 Neonatal Cholestasis. Pediatr Rev. 2014;35(10):436-443. doi:10.1542/pir.35-10-436
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Guideline for the Evaluation of Cholestatic Jaundice in Infants. Joint NASPGHAN/ESPGHAN. J Pediatr Gastroenterol Nutr. 2017;64(1):154-168.
- ↑ Götze T, et al. Neonatal Cholestasis – Differential Diagnoses, Current Diagnostic Procedures, and Treatment. Front Pediatr. 2015;3:43. doi:10.3389/fped.2015.00043
- ↑ 4.0 4.1 Gottesman LE, et al. Etiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjects. BMC Pediatr. 2015;15:192. doi:10.1186/s12887-015-0506-5
- ↑ Neonatal Cholestasis. Merck Manual Professional Edition. 2025.